New NHS treatments helping extend survival for babies with rare muscle-wasting disease

New NHS treatments helping extend survival for babies with rare muscle-wasting disease Nearly three in four babies born with a rare muscle-wasting disease are now surviving for two years or more thanks to advances in NHS treatment, new data shows.

Around 70 children are born with spinal muscular atrophy (SMA) each year in the UK, a rare genetic condition that causes muscle weakness, progressive loss of movement and paralysis. NHS England